Peer Review History
| Original SubmissionJune 7, 2020 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-20-17319 PREVALENCE OF SEXUALLY TRANSMITTED INFECTIONS IN INDIGENOUS BRAZILIAN WOMEN: WATCH OUT FOR Trichomonas vaginalis INFECTION PLOS ONE Dear Dr. Marchioro, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 19 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Catherine E Oldenburg Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 3. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a very good article, with relevant data from a population in which little is known. The data presented here have great relevance in the general context, as it is a gap in the literature and evidence knowledge that tends to generate actions in the field of public health. The article is well structured and meets the steps foreseen for a scientific article. All methodological steps were well described, identifying all the steps performed in this study. However, there is a problem with the objectives proposed in the article. The purpose of the study does not correspond to what is developed in the body of the article. There is a focus throughout the article, from the introduction, analysis, and discussion, on the infection by trichomoniasis, but in the objectives, it informs to evaluate also other STIs, mainly viral hepatitis, HIV, and syphilis. I believe that an important decision needs to be made: better to structure and discuss the data in the light of the other sexually transmitted infections presented in the objective, or focus on the discussion in the analysis of the findings of Trichomonas vaginalis infection. The latter seems to be more viable and close to the one presented so far. Maintaining this analysis alone does not make the work of little relevance. In addition to these indications, I present some specific considerations. Follow below: 1. Title - I didn't understand why part of the title is in capital letters and part is not. ABSTRACT 1. “The prevalence of the 3.73% for T. pallidum and 0.41% for HIV were found in rapid tests.” Note that the prevalence of viral hepatitis was equal to 0. It is also an important fact. 2. Identify that it is a cross-sectional study and the period that the data collection occurred - "A cross-sectional study was 71 conducted between January and December 2018" was only mentioned in the article´s methodology. 3. "The prevalence of STIs, mainly TV, is among the highest in the world". About what? Among women? Compared to what other infections? INTRODUCTION 1. “The main and most prevalent STIs described in the literature are caused by Chlamydia 42 trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis (TV), and Treponema pallidum.” This information is very important. What is the reference? Where is this described? 2. “Trichomoniasis is the most common STI caused by TV.” The information is incomplete. Where? Between who? What is the reference? 3. The focus of the introduction is on trichomoniasis. It scarcely reports on other STIs, especially viral hepatitis, HIV, and syphilis, as indicated in the study's objective. METHODOLOGY 1. “Considering an expected prevalence of 15%” - Prevalence of what? Line 74 2. “Alere DetermineTM 118 Syphilis TP rapid test was used for the diagnosis of syphilis.” It is important to describe what this TR Identifies. Do you investigate antibodies? Do you identify if you have active (acute) syphilis or the presence of antibodies in the body (may indicate a serological scar)? RESULT 1. “USD 283.00” - It´s important to contextualize this information for Brazilians. How was this variable categorized? What is the criterion used for this categorization? What does this mean in the Brazilian context in the period studied? Is it the minimum wage? 2. “human 156 papillomavirus (HPV) infected lesions” - was described in the results without commenting on the summary, methodology, or introduction. It is important to contextualize and present all the data that will be presented in the Results section, at least in the methodology. 3. Present the sociodemographic and behavioral variables in the methodology, describing in detail each variable and its categories. TABLES 1. “Table 2. Distribution of indigenous women based on socioeconomic and behavioral 172 variables” - Is the prevalence of TV not described in this table? In the title, you should mention that too. 2. “Share objects” - What objects are shared? 3. “Condom use” - In which relationships? With a steady partner? With a casual partner? In what period in life? In the last 6 m? Partners in the past 1year “> one and <two” does="" mean="" that="" what=""> DISCUSSION 1. The discussion and analysis of associated factors are restricted to TV infection. The other STIs are not even mentioned. The work is actually about TV. 2. “This difference is might be due to factors, such as bacterial load and test sensitivity [12]. These factors contribute to an underdiagnosis of the disease; once direct microscopy is the only clinical diagnostic method applied [4]. ” - This finding is extremely relevant and should be better discussed. Including, to envision the impact of this in the planning in the actions in the health services. 3. “This data indicate that prevalence rates of infection increases due to socioeconomic factors in this population.” - Line 213-214. The difference in prevalence in these two regions can be explained by the difference in socioeconomic development, but from the data presented we cannot say that it is due to this. Other factors can determine this discrepancy, an example of the community viral load and STI prevalence. 4. “On the other hand, for single women, the risk increases by two times (p = 0.043) and, a strong relationship between TV infection and single women who do not use condoms (p = 0.000) is observed, increasing the risk of having TV infection (p = 0.000) by three times. ” - Line 216-219. This data should be better developed and explained. Condom use can be an important factor in the association between relationship and infection. Discuss this association better. 5. It´s important to discuss better that it is a sampling due to convenience and the bias caused by the study population comes from a health service. 6. In the important conclusion, reinforce the use of more sensitive methods for the diagnosis of VT, considering that there is a discrepancy when comparing the methods of analysis. This is an important finding in this study.</two”> Reviewer #2: The manuscript is well written and the experimental design is adequate to the proposed objectives. The results of the study point to the high prevalence of STI, especially T. vaginalis, in the indigenous population of a region of Brazil and, although the sample size is small, it demonstrates the vulnerability of this specific population to STIs. However, the text needs some adjustments to be published. 1. In the abstract, the authors state in the methods that they will make rapid tests for hepatitis B and C but do not report any information in the results. In addition, the authors should draw some conclusions about the comparison of molecular and T. vaginalis microscopy tests. 2. In the methodology, it would be interesting if in the questionnaire the question about sexual partners included indigenous people and other people outside the community. The authors must inform how the quality control of the DNA extraction of the samples was carried out. The DNA extracted from the culture of ATCC 30236 strain was used as a positive control of the reaction, but we need to make sure that the negative samples had viable DNA. An internal control of the reaction would be interesting, with the amplification of a human gene to guarantee the result. The authors cite the collection of Vaginal samples (line 91) for PCR and Direct microscopic examination. They do not mention blood collection for the performance of rapid tests. Authors should add this information. In line 116, the authors put Federal University of Espírito Santo, Vitória, Brazil after citing the rapid HIV test. Does this mean that the test was the test manufacturer? At the end of the methodology, the authors do not mention which test was performed to detect anti-HCV. The authors should mention in the methodology which procedures were adopted for the women in the study when the studied infections occurred 3. In results, on line 140, the authors claim that 73.86% were from the Guarani-Kaiowá ethnic group. And the rest of the group? Authors must inform ethnicities in the methodology, when mentioning Bororó and Jaguapiru village (line 79) In line 149, hepatitis C is again cited. Authors should add hepatitis C to other topics if they want to continue with the information. Table 1 mentions Cytologic change, however, this information is not included in any previous topic, neither in the abstract nor in the methodology. Authors should review this. Table 1 is confused in the "n in TV PCR" column, as it concerns only T. vaginalis and in the table several other agents are mentioned. In my opinion, this description can be made in the text, without requiring a table representation. The percentage of 25.37% in T. vaginalis in Direct Microscopy was confused and has no reference in the text. The authors do not mention the observation of C. albicans (line 155) in the abstract, nor do they mention in the methodology that they would also perform cytology in the collected cervical samples, to justify the finding of possible injury by HPV and ASC-US. In table 2, the authors cite Ethnicity. This information must also be included in the methodology. In addition, in the table it would be interesting to detail "others" (which is written in Portuguese), because in the Guarani-Nhandeva ethnic group only 3 individuals are mentioned. In table 2, the authors must adjust the decimal places of all percentage results. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-17319R1 Prevalence and factors associated with Trichomonas vaginalis infection in indigenous Brazilian women PLOS ONE Dear Dr. Marchioro, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 30 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Catherine E Oldenburg Academic Editor PLOS ONE Additional Editor Comments (if provided): Thank you for addressing the reviewers' comments. Reviewer 1 has two additional minor suggestions for the article. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The article presented here is better structured and discussed. It is indicated for publication, according to my assessment. The indications made in the first review were corrected satisfactorily, and I don´t have any more major requests. I have only two indications to do. The title of figure 1 (Fig 1. A sampling flowchart showing the number of samples collected and diagnostic methods performed) is found in the middle of the article (line 152-153). This must appear immediately before the figure, and not alone in the middle of the text. The authors return the results data in the discussion, once again, the indication of the tables. I believe that this indication of the tables in the discussion is not necessary (lines 234 and 239), given that it was made in the results. This is an article relevant to the field of public health and the data here exposed are well presented. I take this opportunity to thank you for the invitation and opportunity to review this work. Nothing more to say. Kind regards, F. S. Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Prevalence and factors associated with Trichomonas vaginalis infection in indigenous Brazilian women PONE-D-20-17319R2 Dear Dr. Marchioro, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Catherine E Oldenburg Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-17319R2 Prevalence and factors associated with Trichomonas vaginalis infection in indigenous Brazilian women Dear Dr. Marchioro: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Catherine E Oldenburg Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .